# Coherus Oncology, Inc.: Form 8-K, filed Sep 13, 2024

- Company: [Coherus Oncology, Inc.](/companies/chrs.md) (CIK 1512762)
- Form: 8-K
- Filed: 2024-09-13
- Accepted by EDGAR: Sep 13, 2024, 17:15 ET
- Period: 2024-09-13
- Accession: 0001558370-24-012783
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1512762/000155837024012783/chrs-20240913x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1512762/000155837024012783/

## Items reported

- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1512762/000155837024012783/chrs-20240913x8k.htm

Filed Sep 13, 2024.
Source: SEC EDGAR, the filing index for accession 0001558370-24-012783. Last ingested by Listed: Oct 29, 2026, 08:11 ET. No prices; not investment advice.